期刊文献+

赫赛汀联合盖诺治疗炎性乳腺癌1例 被引量:2

下载PDF
导出
摘要 患者女,31岁,于2006年1月因停经诊断为妊娠。3月发现左乳红肿、疼痛,未引起注意,亦未给予特殊诊治。6月底即孕7月时,因左乳红肿疼痛加重及左乳肿块于某医院就诊,经细针穿刺病理考虑为乳腺癌,后又前往北京某医院行左乳肿块粗针穿刺,病理诊断为左乳浸润性导管癌ER+PR+cerbB2++,结合临床表现诊断为妊娠期左乳炎性乳腺癌。7月26日即孕31周时采取剖宫产术终止妊娠并行双卵巢切除术,病理学诊断为乳腺癌卵巢转移。
作者 刘锦燕
出处 《中国药业》 CAS 2009年第16期25-25,共1页 China Pharmaceuticals
  • 相关文献

参考文献2

二级参考文献12

  • 1储大同.生物和基因治疗[A].孙燕周际昌主编.临床肿瘤内科治疗手册:第4版[C].北京:人民卫生出版社,2003.74-89.
  • 2[1]Stern DF, Hefferman PA, Weinberg RA. p185, a product of the neu proto-oncogene,is a receptorlike protein associated with tyrosine kinase activity[J]. Mol Bell Biol, 1986,6(5): 1729.
  • 3[2]Chong D, Cooke TG, Reeve JR, et al. Quantification of EGFR and c-erbB-2 expression in preinvasive compared to invasive breast cancer[J]. Eur J Cancer, 1999,35(Suppl 4) :203.
  • 4[3]Allred DC, Clark GM, Molina R, et al. Overexpression of HER-2/neu and its relationship with other prognostic factors change during the progression of in situ to invasive breast cancer[J]. Hum Pathol, 1992,23(9) :974.
  • 5[4]Thomas E,Buzdar A,Theriault R,et al. Role of paclitaxel in adjuvant therapy of operable breast cancer: preliminary results of prospective randomised clinical trial[J]. Proc Am Soc Clin Oncol,2000,19:74.
  • 6[5]Strickland LB, Dawson PJ. The hyperplasia-to-carcinoma sequence in the breast: immunohistochemical-histologic correlations [J]. Appl Immunohistochem Mol Morphol, 2000,8 (2): 9.
  • 7[6]Cobleigh MA,Vogel CL,Tripathy D,et al. Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metasta-tic disease [J]. J Clin Oncol, 1999,17 (9): 2639.
  • 8[7]Slamon DJ,Leyland-Jones B,Shak S,et al. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2 [J]. N Engl J Med, 2001, 344(11):783.
  • 9[8]Pegram M,Hsu S,Lewis G,et al. Inhibitory effects of combinations of HER-2/neu antibody and chemotherapeutic agents used for the treatment of human breast cancers[J]. Oncogene, 1999,18(13):2241.
  • 10[9]Leyland-Jones B. Integration of Herceptininto breast cancer treatment algorithms[J]. Anti-Cancer Drugs,2002,13(suppl): 100.

共引文献49

同被引文献17

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部